Advanced search
Publication Cover
Expert Review of Vaccines Volume 10, 2011 - Issue 3
Submit an article Journal homepage
658
Views
6
CrossRef citations to date
0
Altmetric
Meeting Report

Hot topics in the prevention of respiratory syncytial virus disease

Maximillian S Habibi Centre for Respiratory Infection/MRC and Asthma UK Centre, Faculty of Medicine, Imperial College London, London, W2 1PG, UK; Centre for Respiratory Infection/MRC and Asthma UK Centre, Faculty of Medicine, Imperial College London, London, W2 1PG, UK
,
Sanjay Patel Department of Paediatric Infectious Diseases and Immunology, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. [email protected]; Department of Paediatric Infectious Diseases and Immunology, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK. [email protected]
&
Peter Openshaw Centre for Respiratory Infection/MRC and Asthma UK Centre, Faculty of Medicine, Imperial College London, London, W2 1PG, UK; Centre for Respiratory Infection/MRC and Asthma UK Centre, Faculty of Medicine, Imperial College London, London, W2 1PG, UK
Pages 291-293 | Published online: 09 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Ravendra Garg, Pratima Shrivastava & Sylvia van Drunen Littel-van den Hurk. (2012) The role of dendritic cells in innate and adaptive immunity to respiratory syncytial virus, and implications for vaccine development. Expert Review of Vaccines 11:12, pages 1441-1457.
Read now

Articles from other publishers (5)

Antonio Del Vecchio, Caterina Franco, Karin Del Vecchio, Angela Umbaldo, Letizia Capasso & Francesco Raimondi. (2018) RSV prophylaxis in premature infants. Minerva Pediatrica 70:6.
Crossref
M. Cetinkaya, T. K. Oral, S. Karatekin, B. Cebeci, A. Babayigit & Y. Yesil. (2017) Efficacy of palivizumab prophylaxis on the frequency of RSV-associated lower respiratory tract infections in preterm infants: determination of the ideal target population for prophylaxis. European Journal of Clinical Microbiology & Infectious Diseases 36:9, pages 1629-1634.
Crossref
Patricia Jorquera & Ralph Tripp. (2016) Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus. Vaccines 4:4, pages 45.
Crossref
J. Murray, S. Saxena & M. Sharland. (2014) Preventing severe respiratory syncytial virus disease: passive, active immunisation and new antivirals. Archives of Disease in Childhood 99:5, pages 469-473.
Crossref
Pilar Najarro, Richard Angell & Kenneth Powell. (2012) The Prophylaxis and Treatment with Antiviral Agents of Respiratory Syncytial Virus Infections. Antiviral Chemistry and Chemotherapy 22:4, pages 139-150.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.